Trial intelligence / Profile preview

Imatinib Mesylate in Children With Ph+ ALL

NCT01222013Phase 2Suspended

Modality
Small Molecules
01

Overview

A Phase 2 trial of imatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive. Status: suspended.

02

Drugs

03

Conditions

Acute lymphoblastic leukemia, Philadelphia chromosome positive

Beyond the preview

Go deeper on NCT01222013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call